DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global API (Active Pharmaceutical Ingredient) Market - Market Size, Demand Forecasts, Industry Trends and Updates(2014-2020)" report to their offering.
The Global Active Pharmaceutical Ingredients (API) Market is estimated to reach 209.41 billion USD by 2020 at a CAGR of 6.9% for the forecasted period. Branded prescription drugs hold major share in Global API market in 2014
North America held the largest share in Global API market. UK, Germany, Japan, India , China are some of the countries which are significantly contributing for Global API market.
Increasing new drug applications and drug master filing via Indian companies, increasing neurological disorders, cardiovascular diseases, diabetes and cancer are majorly the contributing factors for growth of Global API market. Expansion of distribution channels would further help in fueling the growth of OTC drugs market. However drug price control policies and intense competition among API manufacturers are some of the challenges in Global API market.
Key Topics Covered:
1. Market Size, Demand Forecasts, Industry Trends and Updates (2014-2020)
2. Market Overview
3. Market Dynamics
4. Global API Market Segmentation, Forecasts and Trends - by Revenue
5. By API type
6. By Manufacturing type
7. By Drug type
8. By Therapeutic applications
9. By Region
10. Vendor Market Share Analysis
11. Company Profiles
12. Industry Structure
13. Industry M&As, Consolidations
14. Investment Opportunities
15. Global API market - Road Ahead
Companies Mentioned:
- Albemarle Corporation
- Allergan PLC
- Amgen
- Aurobindo Pharma Ltd
- Boehringer Ingelheim
- Dr. Reddy's Laboratories
- Eli Lilly
- GSK
- Merck
- Mylan Inc
- Novartis
- Pfizer
- Sanofi
- Sigma-Aldrich
- Sun Pharmaceutical Industries Ltd.
-
Teva Pharmaceutical Industries Limited
For more information visit http://www.researchandmarkets.com/research/9t76gf/global_api
